# EDGAR Filing Document

**Accession Number:** 0001617201
**File Stem:** 0001438934-25-001432
**Filing Date:** 2025-8
**Character Count:** 25120
**Document Hash:** 4bb33303c3cfb3602587575abde5f952
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001438934-25-001432.hdr.sgml**: 20250822

**ACCESSION NUMBER**: 0001438934-25-001432

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250822

**EFFECTIVENESS DATE**: 20250822

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Prosight Management, LP
- **CENTRAL INDEX KEY:** 0001617201

**ORGANIZATION NAME:**
- **EIN:** 263706721
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-18450
- **FILM NUMBER:** 251246017

**BUSINESS ADDRESS:**
- **STREET 1:** 5956 SHERRY LANE
- **STREET 2:** SUITE 1365
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225
- **BUSINESS PHONE:** 214-468-0008

**MAIL ADDRESS:**
- **STREET 1:** 5956 SHERRY LANE
- **STREET 2:** SUITE 1365
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75225

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001617201

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Prosight Management, LP

**Address:** 5956 Sherry Lane, Dallas, TX 75225

**Telephone number:** 214-468-0008

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-18450

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                        | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                                          | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   | SHARES VOTED FOR OR AGAINST MANAGEMENT   | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|:---|:---|:---|
| ABCELLERA BIOLOGICS INC.              | 00288U106 | 06/12/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, or Say-on-Pay.                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          12400 |                0 | FOR         | 12400                                    | FOR                         |  |
| ACADIA HEALTHCARE COMPANY, INC.       | 00404A109 | 05/29/2025     | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement.                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          14932 |                0 | FOR         | 14932                                    | FOR                         |  |
| ACADIA HEALTHCARE COMPANY, INC.       | 00404A109 | 05/29/2025     | Advisory vote on the frequency of a non-binding advisory vote on the Compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          14932 |                0 | 1 YEAR      | 14932                                    | FOR                         |  |
| ADC THERAPEUTICS SA                   | H0036K147 | 06/03/2025     | Approving, on an advisory basis under U.S. law, the compensation paid to our Named Executive Officers: The Board of Directors is proposing that the following proposal: "RESOLVED, that the Company's Shareholders approve, on an advisory basis under U.S. law, the compensation of the Company's Named Executive Officers, as disclosed in "Executive Compensation" and the related compensation tables and narrative disclosure in this proxy statement", be approved. | SECTION 14A SAY-ON-PAY VOTES |        4310201 |                0 | FOR         | 4310201                                  | FOR                         |  |
| ADDUS HOMECARE CORPORATION            | 006739106 | 06/18/2025     | To approve, on an advisory, non-binding basis, the compensation of the named executive officers.                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| ADDUS HOMECARE CORPORATION            | 006739106 | 06/18/2025     | To approve, on an advisory non-binding basis, the frequency of holding an advisory, non-binding vote on the compensation of the named executive officers.                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| AILERON THERAPEUTICS, INC.            | 00887A204 | 08/20/2024     | To approve, on a non-binding advisory basis, our named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |           7664 |                0 | FOR         | 7664                                     | FOR                         |  |
| AMICUS THERAPEUTICS, INC.             | 03152W109 | 06/05/2025     | Approval, on an advisory basis, the Company's executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         856542 |                0 | FOR         | 856542                                   | FOR                         |  |
| BIOHAVEN LTD                          | G1110E107 | 05/05/2025     | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          28912 |                0 | FOR         | 28912                                    | FOR                         |  |
| BLUEPRINT MEDICINES CORPORATION       | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| BRIDGEBIO PHARMA, INC.                | 10806X102 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          27019 |                0 | FOR         | 27019                                    | FOR                         |  |
| CAREDX, INC.                          | 14167L103 | 06/12/2025     | Approval, on an advisory basis, of the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          11730 |                0 | FOR         | 11730                                    | FOR                         |  |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | 21833P301 | 05/15/2025     | Approval, on an advisory basis, of the executive compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         113850 |                0 | FOR         | 113850                                   | FOR                         |  |
| CYTOMX THERAPEUTICS, INC.             | 23284F105 | 06/11/2025     | To approve, on a nonbinding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        1614353 |                0 | AGAINST     | 1614353                                  | AGAINST                     |  |
| GALAPAGOS N V                         | 36315X101 | 04/29/2025     | Acknowledgement and approval of the remuneration report.                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         442854 |                0 | FOR         | 442854                                   | FOR                         |  |
| IMMUNOVANT INC                        | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |            205 |                0 | FOR         | 205                                      | FOR                         |  |
| JANUX THERAPEUTICS, INC.              | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          23091 |                0 | FOR         | 23091                                    | FOR                         |  |
| JANUX THERAPEUTICS, INC.              | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          23091 |                0 | 1 YEAR      | 23091                                    | FOR                         |  |
| KURA ONCOLOGY, INC.                   | 50127T109 | 06/05/2025     | Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         599124 |                0 | FOR         | 599124                                   | FOR                         |  |
| LIVANOVA PLC                          | G5509L101 | 06/11/2025     | Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers (''US Say on Pay'').                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          57714 |                0 | FOR         | 57714                                    | FOR                         |  |
| MIRUM PHARMACEUTICALS, INC.           | 604749101 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          61947 |                0 | FOR         | 61947                                    | FOR                         |  |
| PLIANT THERAPEUTICS, INC.             | 729139105 | 06/05/2025     | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         138092 |                0 | AGAINST     | 138092                                   | AGAINST                     |  |
| PROTHENA CORPORATION PLC              | G72800108 | 05/13/2025     | To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          68046 |                0 | FOR         | 68046                                    | FOR                         |  |
| ROCKET PHARMACEUTICALS, INC.          | 77313F106 | 06/18/2025     | Consider and act upon a non-binding, advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         110277 |                0 | FOR         | 110277                                   | FOR                         |  |
| ROIVANT SCIENCES LTD                  | G76279101 | 09/10/2024     | To cast a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          52210 |                0 | FOR         | 52210                                    | FOR                         |  |
| ROIVANT SCIENCES LTD                  | G76279101 | 09/10/2024     | To cast a non-binding, advisory vote on the frequency of future non-binding, advisory votes to approve the compensation of our named executive officers every.                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          52210 |                0 | 1 YEAR      | 52210                                    | FOR                         |  |
| SCHRODINGER, INC.                     | 80810D103 | 06/18/2025     | Approval of an advisory vote on executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              0 |                0 |  |  |  |  |
| SPYRE THERAPEUTICS INC.               | 00773J202 | 05/29/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | FOR         | 1                                        | FOR                         |  |
| SYNDAX PHARMACEUTICALS, INC           | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         202709 |                0 | FOR         | 202709                                   | FOR                         |  |
| TECTONIC THERAPEUTIC, INC             | 878972108 | 06/06/2025     | Advisory approval of the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |         205846 |                0 | FOR         | 205846                                   | FOR                         |  |
| TECTONIC THERAPEUTIC, INC             | 878972108 | 06/06/2025     | Advisory vote on the frequency of stockholder advisory votes on executive compensation.                                                                                                                                                                                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         205846 |                0 | 1 YEAR      | 205846                                   | FOR                         |  |
| ZYMEWORKS INC.                        | 98985Y108 | 12/10/2024     | Advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         295932 |                0 | FOR         | 295932                                   | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Prosight Management, LP

**By (Signature):** Ryan Cappelli

**By (Printed Signature):** Ryan Cappelli

**By (Title):** COO

**Date:** 08/11/2025